Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Teva

Drugmakers Recall Blood Pressure Pills Contaminated with Cancer-Causing Chemical, FDA Says

Teva Pharmaceuticals has recalled over 580,000 bottles of prazosin hydrochloride, a common blood pressure and PTSD medication, after tests detected a nitrosamine impurity, which the FDA warns may cause cancer with long-term exposure.

International Business Times UK

Widely used blood pressure medication recalled over ‘cancer-causing’ chemicals

Pharmaceutical company says it has not yet received any ‘relevant complaints’ related to the recalled medication

The Independent UK

Blood Pressure Medication Recalled Because Of Cancer Risk: What Is Prazosin Hydrochloride

Teva Pharmaceuticals orders a nationwide recall of their Prazosin Hydrochloride capsules.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs

The Trump administration is reportedly planning to exclude imported generic drugs from tariffs.

Benzinga

Helen Skelton knows how to dress for warm but windy weather in wide-leg jeans and a chic wax jacket

Helen’s fail-safe autumn outfit formula makes dressing for tricky transitional weather a breeze

Woman & Home

Struggling to style long denim shorts? Helen Skelton pulls them off effortlessly with her striped blouse and chunky sandals

As we cling to the warm summer weather, denim shorts are a staple – and Helen’s effortlessly casual styling is perfect inspiration

Woman & Home

Teva Launches Generic GLP-1 Weight Loss Drug With FDA Nod For Saxenda

As the demand for affordable healthcare options grows, the pharmaceutical industry is increasingly focused on developing generic drugs to expand access and reduce costs. This trend is driving major players to seek FDA approvals for generic versions of popular medications, reshaping the competitive landscape and providing more choices for consumers.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Teva Aventrail Running Sandals review: these maximalist open-toe trail shoes are a bit of a plot twist

Cushioned to the max, these trail-running sandals are comfortable underfoot and surprisingly capable on straightforward trails

Advnture

Teva Pharma Boosts Outlook For Key Innovative Drugs Austedo, Ajovy, Uzedy

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy.

Benzinga

Generic Revlimid Fades, But Teva's Broader Generics Outlook Remains Strong

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will release its second-quarter 2025 financial results tomorrow, July 30.

Benzinga

Chic, ultra-curated and small-batch: how second-hand fashion is moving on from Vinted

Style-conscious shoppers are increasingly turning to small-batch fashion sites to curate their look for them. As second-hand September kicks off, we meet the people making it happen

Evening Standard

Teva Pharmaceutical (TEVA) Just Flashed a Statistically Viable Signal for Bullish Traders

Using principles from applied game theory, options traders may have an intriguing opportunity with TEVA stock.

Barchart

The best trending sandals that don’t wreck your feet

While you may be attached to strappy sandals – here are some trending options that won’t leave you with blisters.

The Independent UK

Victoria Beckham swears by this flattering jeans shape, and her tomato red polo top makes them feel so fresh for 2025

She was pictured in Paris, wearing the denim style she's championed for over a decade

Woman & Home

Get all your
news in one place.

100’s of premium titles.
One news app.

Woman & Home

It's true: it doesn't get any chicer than Demi Moore's white turn-up jeans and comfy Teva sandals

We've found similar Tevas for under £30

Marie Claire

According to Mary-Kate Olsen, these Affordable Sandals are the Only Style you Need this Summer

And no, they're not from The Row

Sandals on the trail: smart swap or risky move?

Hiking sandals are making a comeback as an outdoor staple, but are they really adventure-ready?

The Guardian - UK

EU drug companies warn of exodus to US as Trump threatens import tariffs

Von der Leyen urged to take ‘rapid and radical action’ as president says tariffs on pharmaceuticals coming ‘shortly’

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

These Are the 2 Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip?

This article highlights the two worst-performing S&P 500 stocks in 2025 and discusses whether they present a buying opportunity.

Advnture

Can't wait for Hoka's adventure sandal to be released? Teva's new technical Grandview Max has arrived, and it's ready to tackle the trails

Teva has been crafting technical sandals for over 40 years

MarketBeat

Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now

Teva Pharmaceuticals is the world's largest generic drug maker with over 500 generics in its portfolio, but shares sold off on its recent earnings, buying opp?

MarketBeat

2 Generic Drug Stocks Ready to Surge in 2025

Explore how Teva Pharmaceuticals and Viatris are leading the generics industry with strong growth, robust pipelines, and strategies for 2025 success.

Woman & Home

Teva Grandview GORE-TEX review: 'Triumphant' on tricky trails with supreme support and unbeatable waterproofing

The Teva Grandview GORE-TEX is an all-rounder for winter weather. Here, hiker Susan Griffin reveals why it's a must-buy this year

Top News

EU Fines Teva 0M For Misusing Patent Protection

European Commission fines Teva over 460 million euros for improper practices related to Copaxone drug and disparagement of competitor.

The Independent UK

EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug

The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis drug and for disparaging a rival company’s development of a competing medicine

1 2 3 4

People

Deborah SheridanTaylor

11 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Commission

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.